eBiomedicine丨12-Jan-24
Efficacy, safety and genomic analysis of SCT200, an anti-EGFR monoclonal antibody, in patients with fluorouracil, irinotecan and oxaliplatin refractory RAS and BRAF wild-type metastatic colorectal can
BNR‘s 108-gene panel | Colorectal Cancer
Learn More